Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 2001 Nov;47:2242–2247.

Prevention and treatment of influenza A and B.

B Mintzes, K Bassett, J Wright
PMCID: PMC2018458  PMID: 11768922

Full Text

The Full Text of this article is available as a PDF (47.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beyer W. E., de Bruijn I. A., Palache A. M., Westendorp R. G., Osterhaus A. D. Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Arch Intern Med. 1999 Jan 25;159(2):182–188. doi: 10.1001/archinte.159.2.182. [DOI] [PubMed] [Google Scholar]
  2. Drinka P. J., Gravenstein S., Schilling M., Krause P., Miller B. A., Shult P. Duration of antiviral prophylaxis during nursing home outbreaks of influenza A: a comparison of 2 protocols. Arch Intern Med. 1998 Oct 26;158(19):2155–2159. doi: 10.1001/archinte.158.19.2155. [DOI] [PubMed] [Google Scholar]
  3. Govaert T. M., Dinant G. J., Aretz K., Masurel N., Sprenger M. J., Knottnerus J. A. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ. 1993 Oct 16;307(6910):988–990. doi: 10.1136/bmj.307.6910.988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Govaert T. M., Thijs C. T., Masurel N., Sprenger M. J., Dinant G. J., Knottnerus J. A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994 Dec 7;272(21):1661–1665. [PubMed] [Google Scholar]
  5. Gross P. A., Hermogenes A. W., Sacks H. S., Lau J., Levandowski R. A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995 Oct 1;123(7):518–527. doi: 10.7326/0003-4819-123-7-199510010-00008. [DOI] [PubMed] [Google Scholar]
  6. Hayden F. G., Osterhaus A. D., Treanor J. J., Fleming D. M., Aoki F. Y., Nicholson K. G., Bohnen A. M., Hirst H. M., Keene O., Wightman K. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med. 1997 Sep 25;337(13):874–880. doi: 10.1056/NEJM199709253371302. [DOI] [PubMed] [Google Scholar]
  7. Nicholson K. G., Aoki F. Y., Osterhaus A. D., Trottier S., Carewicz O., Mercier C. H., Rode A., Kinnersley N., Ward P. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet. 2000 May 27;355(9218):1845–1850. doi: 10.1016/s0140-6736(00)02288-1. [DOI] [PubMed] [Google Scholar]
  8. Nicholson K. G., Nguyen-Van-Tam J. S., Ahmed A. H., Wiselka M. J., Leese J., Ayres J., Campbell J. H., Ebden P., Eiser N. M., Hutchcroft B. J. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet. 1998 Jan 31;351(9099):326–331. doi: 10.1016/S0140-6736(97)07468-0. [DOI] [PubMed] [Google Scholar]
  9. Treanor J. J., Hayden F. G., Vrooman P. S., Barbarash R., Bettis R., Riff D., Singh S., Kinnersley N., Ward P., Mills R. G. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA. 2000 Feb 23;283(8):1016–1024. doi: 10.1001/jama.283.8.1016. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES